tbuckley/cabot-search huggingface dataset:
MicroRNA-155 Modulates Transforming Growth Factor-β Signaling In Chronic Lymphocytic Leukemia through Targeting of Casein Kinase γ Isoform 2
Authors: Jan K. Davidson-Moncada, Taotao Zhang, Piali Mukherjee, Paul Hakimpour, Richard R. Furman, Nina Papavasiliou, Wayne Tam
Journal: Blood (2010)
SAT0520 Indications and Clinical Impacts of Magnetic Resonance Imaging of The Knee in Older Patients: Are We Choosing Wisely?
Authors: M.-E. Parent, F. Vézina, N. Carrier, C. Giguère, A. Masetto
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> The use of magnetic resonance imaging (MRI) seems to be increasing in patients with gonalgia. Findings such as osteoarthritis and meniscal damages are very prevalent in older patients, often simultaneously [1–3]. These findings are of undetermined significance, as invasive therapeutic procedures provide no additional benefit [4]. <h3>Objectives</h3> The aim of this study is to analyze MRI indications and clinical impact in this population in our center. <h3>Methods</h3> We retrospectively analyzed 215 medical records of patients older than 50 yo having undergone a knee MRI in 2009. Medical charts were reviewed up to 2014 for: patient characteristics, MRI indication, ordering physician specialty, radiography prior to MRI, MRI findings and clinical impacts of the MRI. <h3>Results</h3> Patient9s average age was 60.6±7.5. Main MRI indications were meniscopathy: 148 (68.8%) and chronic pain: 92 (42.8%). Most MRIs were ordered by general practitioners (GP): 148 (68.8%) and orthopedic surgeons (OS): 55 (25.6%). Chronic pain investigation was significantly higher in GPs than in OS (48.0% vs 27.3%, p=0.008). Findings show that 185 (86%) patients had osteoarthritis (OA) and 170 (79.1%) had meniscal lesions. Overall, 87 (40.5%) patients were seen by an OS and 27 (31%) of them underwent an invasive intervention. Among the 81 patients with moderate-to-severe OA on MRI, 36 (46%) had evidence of moderate-to-severe OA on a previous plain radiography, 28 (34.6%) were seen by an OS, and 3 (3,7%) underwent a meniscectomy. <h3>Conclusions</h3> Our study reproduces the known association between OA and degenerative meniscal changes in older patients. About half of our cohort could have been appropriately diagnosed and treated based on available radiographic information, thus avoiding the MRI and subsequent OS evaluation. Meniscectomy - an MRI dependent procedure - was rare, particularly in patients with advanced OA. Educational and pragmatic measures must be emphasized to limit the inappropriate use of this costly imaging modality. <h3>References</h3> Boden SD, Davis DO, Dina TS, Stoller DW, Brown SD, Vailas JC, et al. A prospective and blinded investigation of magnetic resonance imaging of the knee. Abnormal findings in asymptomatic subjects. Clin Orthop Relat Res. 1992 Sep;(282):177–85. Kornick J, Trefelner E, McCarthy S, Lange R, Lynch K, Jokl P. Meniscal abnormalities in the asymptomatic population at MR imaging. Radiology. 1990 Nov;177(2):463–5. Bhattacharyya T, Gale D, Dewire P, Totterman S, Gale ME, McLaughlin S, et al. The clinical importance of meniscal tears demonstrated by magnetic resonance imaging in osteoarthritis of the knee. J Bone Joint Surg Am. 2003;85-A:4–9. Katz JN, Brophy RH, Chaisson CE, de Chaves L, Cole BJ, Dahm DL, et al. Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med. 2013 May 2;368(18):1675–84. <h3>Disclosure of Interest</h3> None declared
SP0060 Impact on Scoring - Machine and Experience
Authors: G. Tamborrini
Journal: Annals of the Rheumatic Diseases (2016)

In this practical ultrasound session we discuss exemplary studies demonstrating the feasibility and reproducibility of scoring systems for e.g. Rheumatoid Arthritis. We emphasis the importance of the quality of ultrasound machines, the correct settings and the training of sonographers for the implementation of ultrasound scoring in the routine daily care of RA patients. We promote consensus guidelines and high quality training to improve musculoskeletal ultrasound reliability. <h3>Literature</h3> Brulhart L, Zufferey P, Tamborrini G, Ziswiler HR Clinical and Experimental Rheumatology 2014; 32: Zufferey P, Tamborrini G et al Swiss Med Wkly. 2013;143:w13861 Torp-Pedersen ST, Terslev L. Ann Rheum Dis 2008;67:1439 <h3>Disclosure of Interest</h3> None declared
Outcomes after Double Umbilical Cord Blood Transplantation in Children: A Survey on Behalf of Eurocord and PDWP-EBMT
Authors: Federica Giannotti, Annalisa Ruggeri, Gerard Michel, Jean-Hugues Dalle, Tracey O'Brien, Amal Al-Seraihy, Rachael Hough, Pierre-Simon Rohrlich, Charlotte Jubert, Henrique Bittencourt, Virginie Gandemer, Pascal Chastagner, Elena Skorobogatova, Anne Sirvent, Fanny Rialland, Sarah Lawson, Bruno Lioure, Paul Veys, Peter J. Shaw, Jakob Passweg, Zhanna Shekhovtsova, Fernanda Volt, Christina Peters, Peter Bader, Eliane Gluckman, Vanderson Rocha
Journal: Blood (2014)
OC-086 The Characteristics of Ileo-Colonic Neuroendocrine Tumours Identified in the UK Bowel Cancer Screening Programme (BCSP)?
Authors: R Basuroy, K O’Donnell, C Brooks, R Srirajaskanthan, J Ramage
Journal: Gut (2016)

<h3>Introduction</h3> Neuroendocrine tumours (NETs) identified during BCSP, in particular rectal NETs, are reported to be smaller and earlier stage than those identified otherwise. There is no published data on the characteristics of NETs identified as part of the UK BCSP. <h3>Methods</h3> Data requests were made to UK BCSP and NET related queries were run which identified 146 patients between 2005–14. Written requests to individual BCSP practitioners to complete a proforma about endoscopy, histology, and secondary therapy assesments (including supplemental anonymised reports). <h3>Results</h3> 102 written proformas were returned for analysis with sites, sizes and grades outlined below. Colorectal cancer was identified as a co-malignancy in 7% of patients with NETs. <h3>Conclusion</h3> 50% of NETs identified are rectal NETs which are invariably small (&lt;10mm), low grade and early stage. 27% of NETs identified are small bowel NETS that can have invasive, nodal and metastatic disease. The results corroborate findings of early disease in rectal NETs but additionally informs on advanced disease in NETs from other primary sites. <h3>Disclosure of Interest</h3> None Declared
Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging Agents
Authors: Reinier Hernandez, Sandra Heskamp, Mark Rijpkema, Desirée L. Bos, David M. Goldenberg, William J. McBride, Alfred Morgenstern, Frank Bruchertseifer, Weibo Cai, Otto C. Boerman
Journal: Theranostics (2016)

Despite the large interest in nuclear/optical multimodality imaging, the effect of radiation on the fluorescence of fluorophores remains largely unexplored.Herein, we report on the radiobleaching of cyanine fluorophores and describe conditions to provide robust radioprotection under practical (pre)clinical settings.We determined the radiosensitivity of several cyanine fluorescent compounds, including IRDye 800CW (800CW) and a dual modality imaging tetrapeptide containing DOTA as chelator and Dylight 800 as fluorophore, exposed to increasing activities of 111 In, 68 Ga, or 213 Bi (γ, EC/β, and α emitter, respectively).An activity and type of radiation-dependent radiation-induced loss of fluorescence, radiobleaching, of 800CW was observed upon incubation with escalating activities of 111 In, 68 Ga, or 213 Bi. 68 Ga showed the largest radiolytic effect, followed by 111 In and 213 Bi.The addition of oxygen radical scavengers including ethanol, gentisic acid, and ascorbic acid (AA), provided a concentration dependent radioprotective effect.These results supported the hypothesis of a free radical-mediated radiobleaching mechanism.AA provided the most robust radioprotection over a wide range of concentrations and preserved fluorescence at much higher radioactivity levels.Overall, both near-infrared fluorescent compounds displayed similar sensitivity, except for 213 Bi-irradiated solutions, where the dual modality construct exhibited enhanced radiolysis, presumably due to direct radiation damage from α particles.Concurrently, AA was not able to preserve fluorescence of the dual-modality molecule labeled with 213 Bi.Our findings have important consequences for several research areas including ROS sensing, radiation-mediated drug release (uncaging), fluorescent dosimetry, and in the preparation of dual-modality radiopharmaceuticals.
Quantitative Changes of T Helper Cell 3 and CD4+CD25+T Regulator Cells in Peripheral Blood and the Serum Levels of TGF-β1 of the Patients with Severe Aplastic Anemia.
Authors: Zonghong Shao, Meifeng Tu, Hong Liu, Guangsheng He, Jun Shi, Jie Bai, Yanran Cao, Huaquan Wang, Limin Xing, Zhenzhu Cui, Juan Sun, Hairong Jia, Huisu Chen, Yanping Xue, Chongli Yang
Journal: Blood (2006)
The Promising Strategy of Mycophenolate Mofetil Dosing to Prevent Moderate- to Severe-Acute Graft-Versus-Host Disease.
Authors: Shinichiro Nishikawa, Atsuo Okamura, Motohiro Yamamori, Yoshio Katayama, Manabu Shimoyama, Toshimitsu Matsui
Journal: Blood (2008)
The FLT3-D324N Variant Is a Functionally Silent Polymorphism in the FLT3 Gene and May Be Associated with a Higher Risk for AML.
Authors: Susanne Schnittger, Tobias M. Kohl, Nina Leopold, Claudia Schoch, Wolfgang Kern, Peter Lohse, Wolfgang Hiddemann, Torsten Haferlach, Karsten Spiekermann
Journal: Blood (2004)
A Phase II Study of Bortezomib (Velcade ®), Cyclophosphamide (Cytoxan®), Thalidomide (Thalomid®) and Dexamethasone as First-Line Therapy for Multiple Myeloma
Authors: William Bensinger, Sundar Jagannath, Robert Vescio, Elber S. Camacho, Jeffrey Lee Wolf, David H Irwin, Gerardo Capo, Marti McKinley, Phyllis Potts, David H. Vesole, Amitabha Mazumder, Dixie-Lee Esseltine, Pamela Becker, John Crowley, Brian GM Durie
Journal: Blood (2008)
Assessment Of Drug Toxicity In Patients With and Without Renal Impairment Receiving Lenalidomide At a Large Academic Institution
Authors: Houry Leblebjian, Wanling Xie, Paul G. Richardson, Irene M. Ghobrial, Christy Harris, Robert L Schlossman, Claudia E. Paba-Prada, Nikhil C. Munshi, Sylvia Bartel, Kenneth C. Anderson, Edie A. Weller, Jacob P. Laubach
Journal: Blood (2013)
Identification and Characterization of a Human Platelet Glycoprotein VI Peptidomimetic Permitting Molecular Imaging of Fibrosis.
Authors: Martine Jandrot-Perrus, Julien Muzard, Laure Sarda-Mantel, Stéphane Loyau, Alain Meulemans, Liliane Louedec, Florence Hervatin, Jean-Baptiste Michel, Dominique Le Guludec, Philippe Billiald
Journal: Blood (2008)
Large Interindividual Differences in In Vitro Calicheamicin Sensitivity May Underly Gemtuzumab Ozogamicin Resistance in Acute Myeloid Leukemia (AML).
Authors: Bianca F. Goemans, Gertjan J.L. Kaspers, Susanne J.H. Vijverberg, Anne H. Loonen, Ursula Creutzig, Karel Hahlen, Dirk Reinhardt, Brenda E.S. Gibson, Jacqueline Cloos, Christian M. Zwaan
Journal: Blood (2005)
A Decision Analysis of Unrelated Hematopoietic Stem Cell Transplantation for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia In First Remission Who Lack An HLA-Matched Sibling
Authors: Shinichi Kako, Satoshi Morita, Hisashi Sakamaki, Hiromitsu Iida, Mineo Kurokawa, Koichi Miyamura, Heiwa Kanamori, Masamichi Hara, Naoki Kobayashi, Yasuo Morishima, Keisei Kawa, Taiichi Kyo, Toru Sakura, Itsuro Jinnai, Jin Takeuchi, Yasushi Miyazaki, Shuichi Miyawaki, Kazunori Ohnishi, Tomoki Naoe, Yoshinobu Kanda
Journal: Blood (2010)
The Legacy of Maurice Raynaud
Authors: Arpan V. Prabhu, Chester V. Oddis
Journal: JAMA Dermatology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Dermatology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Dermatology journal
AB0982 Dichotomous Scoring of Ra Ultrasound Inflammation Demonstrates Good Responsiveness Compared To Semi-Quantitative Scoring When Using Novel Joint Selection Methods: Table 1.
Authors: Y.K. Tan, J.C. Allen, W.K. Lye, P.G. Conaghan, L.C. Chew, J. Thumboo
Journal: Annals of the Rheumatic Diseases (2016)

<h3>Background</h3> Novel joint selection methods using semi-quantitative scoring (SQS) of ultrasound (US) joint inflammation (power Doppler (PD) vascularity and grey-scale synovial hypertrophy (GSSH)) have shown good sensitivity to change versus existing methods and DAS28 in RA (1). However SQS may have more variability than dichotomous scoring (DS) as SQS requires grading across multiple categories. <h3>Objectives</h3> Compare responsiveness of DS of US joint inflammation versus SQS using 2 novel and 2 existing joint selection methods. <h3>Methods</h3> Novel methods were Individualized US [IUS], which selects up to 7 or 12 most inflamed joints on US and Individualized Composite-US [ICUS], which additionally considers joint symptoms. Existing methods were a pre-defined 7-joint count and a 12-joint count derived from an US data reduction method. PD vascularity and GSSH at the joints were scored via a DS system [USDSS] as Y/N or via a SQS system [USSQS] on a 0–3 severity scale. Both systems scored tenosynovitis (PD and GS changes), tender and swollen joints as Y/N. Joint pain was scored as Y/N (with USDSS) or using a 0–3 severity scale (with USSQS). Responsiveness at 3 months was measured using the standardized response mean (SRM). Relative gains in SRM magnitude (SRM-Gains) were reported comparing novel to existing methods. <h3>Results</h3> 20 RA subjects (mean DAS28 at baseline and 3-months =4.68 and 4.19, respectively) starting/escalating on DMARDs and corticosteroid therapy were followed for 3 months. SRMs using existing methods were modest for both USDSS and USSQS (ranged from 0.30 to 0.49). SRMs ranged from 0.94 to 1.06 using novel methods with both systems. There were substantial SRM-Gains (ranged from 1.94 to 3.47) for both systems using ICUS and IUS with the 7 or 12 joint approaches. <h3>Conclusions</h3> Results of this small study suggest USDSS may be as responsive as USSQS (both had substantial SRM-Gains) using novel joint selection methods. <h3>References</h3> Tan YK et al. J Rheumatol. 2016;43(1):34–7 <h3>Acknowledgement</h3> NCS grant and Estate of Tan Sri Khoo Teck Puat for funding support and the NUS <h3>Disclosure of Interest</h3> None declared
A Novel Orally Available Parthenolide Analog Selectively Eradicates AML Stem and Progenitor Cells.
Authors: Monica L. Guzman, Randall M. Rossi, Xiaojie Li, Cheryl Corbett, Duane C. Hassane, Timothy Bushnell, Martin Carroll, Edmund Sullivan, Sundar Neelakantan, Peter A. Crooks, Craig T. Jordan
Journal: Blood (2006)
OC-051 Outcomes of SM Invasive Barrett’s Cancers Following Endoscopic Resection: Radical Intervention is not Always Required?: Abstract OC-051 Table 1
Authors: F Chedgy, S Subramaniam, K Kandiah, S Thayalasekaran, P Bhandari
Journal: Gut (2016)

<h3>Introduction</h3> Endoscopic resection (ER) of Barrett’s cancer with curative intent is extremely effective for lesions limited to the mucosal layer of the oesophagus. Lesions extending beyond the muscularis mucosae into the submucosa are considered for radical therapy due to risk of lymph node metastases. Radical treatment is not without risk, reported mortality of oesophagectomy is 2–5%. <h3>Methods</h3> All patients referred for ER of Barrett’s cancer had data collected prospectively between 2006 and 2015. The database was interrogated by independent researchers blinded to the endoscopic procedures for patients with SM invasive cancers. <h3>Results</h3> 261 endoscopic resections were performed in 182 patients during the study period. 26 (14%) patients had SM invasion following ER. 12 had undergone endoscopic submucosal dissection (ESD) and 14 endoscopic mucosal resection (EMR). 22 (85%) lesions were superficially submucosally invasive (SM1), 4 were &gt;SM1 (15%). Table 1 shows outcomes after ER. Mean disease free survival was 4.31 years (Range 0.7 to 10.8) in this cohort. 3 patients died of recurrent cancer, 3 patients died of co-morbid conditions. All 9 patients in the endoscopy group were clear of cancer at follow up. There was 1 recurrence treated with further ER. Of the 6 patients undergoing surgery 5 had no residual neoplasia in the oesophagectomy specimen (pTxN0M0). 1 patient had a pT1N0M0 cancer with LVI and signet ring cells and died 2 years after surgery. 1 patient was considered for surgery but was turned down due to comorbidities and subsequently died of cancer 6 years following ER. 3 patients have been discharged to their referring centres for consideration of surgery. 7 patients underwent chemoradiotherapy. 6 of 7 patients treated with chemoradiotherapy were clear of recurrence on follow up. 1 patient developed recurrence of cancer and died 2 years after ER. <h3>Conclusion</h3> This data challenges the current paradigm of radical therapy following ER of SM1 Barrett’s cancers. Outcomes for patients managed endoscopically are excellent. 5 patients undergoing surgery in our cohort had no residual disease in the oesophagectomy specimen and potentially could have undergone endoscopic follow up alone. Patients found to have SM1 lesions without poor prognostic features can effectively be managed without radical intervention. SM invasive cancers require an individualised management plan tailored to histology and co-morbidities. There does not appear to be a demonstrable difference between chemoradiotherapy and surgery. <h3>Disclosure of Interest</h3> None Declared
Sustainability and transformation plans: a troubled start
Authors: Nick Black, Nicholas Mays
Journal: BMJ (2016)

These plans can work despite the challenges if we make the right changes now 

Ever since 1948 the NHS in England has needed an intermediate tier between the national and the local to plan and govern services. So, it is no surprise that three years after the 2012 Health and Social Care Act removed strategic health authorities, NHS England reintroduced regional governance in the form of sustainability and transformation plans (STPs). The need for coherent planning has been heightened by the act’s fragmentation of the system and exacerbated by the current extraordinary financial constraints and rising demand.

STPs are a way of introducing regional planning without formal reorganisation, a workaround designed to avoid the cost of creating an intermediate tier and legislative changes. NHS England recognises that successful transformation of health and social care, envisaged in the Five Year Forward View ,1 is unlikely without regional leadership driving change. STPs are to bring together NHS commissioners and providers with local government, and to inject greater collective urgency into …
One Step Quantitative Molecular Approach for Detection of BCR/ABL Translocation and for Monitoring and Follow up of the Minimal Residual Disease in CML Patients Under Tyrosine Kines Inhibitors Treatment
Authors: Filomena Daraio, Davide Barberis, Francesca Crasto, Giovanna Rege-Cambrin, Cristina Olivo, Matteo Renzulli, Rosy Volpi, Roberta Lorenzatti, Carmen Fava, Enrico Gottardi, Giuseppe Saglio
Journal: Blood (2012)
Validation of FLT3-ITD As a Therapeutic Target in Human Acute Myeloid Leukemia
Authors: Catherine C. Smith, Jason Chin, Qi Wang, Sara Salerno, Lauren E. Damon, Jeremy P. Hunt, Mark J. Levis, Alexander E Perl, Kevin Travers, Susana Wang, Andrew Kasarskis, Eric Schadt, John Kuriyan, Neil Shah
Journal: Blood (2011)
Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open Question
Authors: Tomasz Burzykowski, Everardo D. Saad, Marc Buyse
Journal: JAMA Oncology (2016)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
SP0141 The Point of View of Physician. Social Media: Pros and Cons of Sharing Patient and Physician Personal Experience
Authors: E. Nikiphorou
Journal: Annals of the Rheumatic Diseases (2016)

The world of social media (SM) is rapidly evolving and we are experiencing a new era of online communication and social interaction. Aside from SM platforms being used for recreational/leisure purposes, in more recent years, they are being increasingly used for professional communication and for sharing knowledge and information. SM platforms like Twitter and Facebook are commonly used at conferences and other educational events, eliminating geographical barriers and enabling rapid dissemination of information. Educational activities on SM platforms like Twitter include journal clubs, participation in clinical/research quizzes and problem-solving. Communication between physicians and other health care professionals and patients on SM is becoming increasingly popular. SM allows for patients and physicians to connect on a different level; yet, this kind of interaction has both advantages and disadvantages. If, however, SM is used appropriately, it can be an incredibly powerful means of good communication, learning and development. <h3>Disclosure of Interest</h3> None declared
MEK Inhibition Modulates the Growth of Nf1 mutant Hematopoietic Cells and Induces Clinical Improvement in a Murine Model of Juvenile Myelomonocytic Leukemia (JMML)
Authors: Tiffany Y. Chang, Kimberly Krisman, Emily Rose Harding-Theobald, Benjamin S. Braun, Kevin M. Shannon
Journal: Blood (2011)
A Chromatin Modifier SATB1 Promotes Lymphocyte Production From Primitive Hematopoietic Stem/Progenitor Cells
Authors: Yusuke Satoh, Takafumi Yokota, Hirokazu Tanaka, Koichi Kokame, Toshiyuki Miyata, Itaru Matsumura, Kenji Oritani, Yuzuru Kanakura
Journal: Blood (2010)
Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer M. Sinnott, Rachel S. Kelly, Lorelei A. Mucci, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974–82
Authors: Herney Andrés García-Perdomo, Ramiro Manzano Nunez
Journal: European Urology (2016)